First iPS Cell Trial Underway But A Long Way To Go
This article was originally published in PharmAsia News
Executive Summary
Researchers in Japan have "dosed" the initial patient in the world's first clinical trial involving a regenerative therapy based on the country's flagship induced pluripotent stem (iPS) cell technology.